These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25467089)

  • 1. Clinical heterogeneity in the same generation of siblings with GCK/MODY 2.
    Maltoni G; Zucchini S; Martini AL; Marasco E; Mantovani V; Pession A
    Diabetes Res Clin Pract; 2015 Jan; 107(1):e1-3. PubMed ID: 25467089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of the glucokinase impaired function - GCK MODY today.
    Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
    Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
    Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
    Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age.
    Odem J; Munzinger E; Violand S; Van Morlan A; Rife D; Bachrach B
    Pediatr Diabetes; 2009 Dec; 10(8):550-3. PubMed ID: 19515026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
    Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
    Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges.
    Timsit J; Ciangura C; Dubois-Laforgue D; Saint-Martin C; Bellanne-Chantelot C
    Front Endocrinol (Lausanne); 2021; 12():802423. PubMed ID: 35069449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY.
    Weinert LS; Silveiro SP; Giuffrida FM; Cunha VT; Bulcão C; Calliari LE; Della Manna T; Kunii IS; Dotto RP; Dias-da-Silva MR; Reis AF
    Diabetes Res Clin Pract; 2014 Nov; 106(2):e44-8. PubMed ID: 25174781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental mild hyperglycemia in children: two MODY 2 families identified in Brazilian subjects.
    Caetano LA; Jorge AA; Malaquias AC; Trarbach EB; Queiroz MS; Nery M; Teles MG
    Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):519-24. PubMed ID: 23295292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucokinase mutations in young children with hyperglycemia.
    Codner E; Deng L; Pérez-Bravo F; Román R; Lanzano P; Cassorla F; Chung WK
    Diabetes Metab Res Rev; 2006; 22(5):348-55. PubMed ID: 16444761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry.
    Dickens LT; Letourneau LR; Sanyoura M; Greeley SAW; Philipson LH; Naylor RN
    Acta Diabetol; 2019 Apr; 56(4):405-411. PubMed ID: 30535721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of mutations in the glucokinase gene in people clinically characterized as MODY2 without a family history of diabetes.
    Lopez AP; de Dios A; Chiesa I; Perez MS; Frechtel GD
    Diabetes Res Clin Pract; 2016 Aug; 118():38-43. PubMed ID: 27289208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the biochemical characteristics of a novel glucokinase gene mutation.
    Shen Y; Cai M; Liang H; Wang H; Weng J
    Hum Genet; 2011 Mar; 129(3):231-8. PubMed ID: 21104275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
    García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
    Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel glucokinase gene mutation in the first Macedonian family tested for MODY.
    Kocova M; Elblova L; Pruhova S; Lebl J; Dusatkova P
    Diabetes Res Clin Pract; 2017 Aug; 130():86-89. PubMed ID: 28575730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
    BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucokinase mutations in pediatric patients with impaired fasting glucose.
    Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
    Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young.
    Maltoni G; Zucchini S; Scipione M; Mantovani V; Salardi S; Cicognani A
    Pediatr Diabetes; 2012 Mar; 13(2):208-12. PubMed ID: 21696527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene.
    Bennett K; James C; Mutair A; Al-Shaikh H; Sinani A; Hussain K
    Pediatr Diabetes; 2011 May; 12(3 Pt 1):192-6. PubMed ID: 21518409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
    Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
    Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.